Cargando…
Osimertinib: Pneumonitis and interstitial lung disease: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990110/ http://dx.doi.org/10.1007/s40278-022-13066-y |
Ejemplares similares
-
Osimertinib: Pneumonitis: case report
Publicado: (2021) -
Osimertinib‐induced severe interstitial lung disease: A case report
por: Fan, Mengdi, et al.
Publicado: (2019) -
Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinoma
por: Satoh, Shingo, et al.
Publicado: (2017) -
Successful treatment with afatinib following the failure of osimertinib rechallenge with osimertinib-induced interstitial lung disease: A case report
por: Sato, Yozo, et al.
Publicado: (2021) -
Early‐onset interstitial pneumonitis in a patient with advanced non‐small cell lung cancer treated with crizotinib and osimertinib
por: Cheng, Yuan, et al.
Publicado: (2021)